The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity—such as individuals receiving immune-suppressive drugs for autoimmune diseases—can become chronically infected. ...
Mar 16, 2021
0
172
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable—that is, remain higher over ...
Nov 1, 2021
2
233
UCLA researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes COVID-19, in the airways of the lungs.
Nov 17, 2020
0
40
When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection ...
Mar 30, 2021
0
436
As researchers around the world search for safe and effective drug treatments and vaccines, SARS-CoV-2, the virus that causes COVID-19 appears to be very stable in terms of its genomic, or complete DNA, makeup.
May 12, 2020
0
3
National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or "nanobodies," against SARS-CoV-2 that were produced by a llama named Cormac. Preliminary results published in Scientific Reports ...
Dec 22, 2020
0
64
The virus that causes COVID-19 belongs to the family of coronaviruses, "corona" referring to the spikes on the viral surface. These spikes are not static—to infect cells, they change shapes. Maolin Lu, an associate research ...
Feb 25, 2021
0
10
Herd immunity—when the prevalence of immunity to a virus in a population reaches "herd" levels (enough people are resistant to keep an epidemic from growing)—has been considered by some countries as a strategy to combat ...
Aug 26, 2020
0
12
There are common vulnerabilities among three lethal coronaviruses, SARS-CoV-2, SARS-CoV-1 and MERS-CoV, such as frequently hijacked cellular pathways, that could lead to promising targets for broad coronavirus inhibition, ...
Oct 15, 2020
0
71
Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune ...
Nov 30, 2020
0
98
